Recent Finacing
Recent Raise
Relief Therapeutics is a clinical-stage biotechnology company developing atexakin alfa for peripheral neuropathy, holding licensed IP and global commercialization rights from Merck KGaA.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Relief Therapeutics.
